CA2432278A1 - Methodes et compositions relatives a un facteur nucleaire regulateur specifique du muscle cardiaque - Google Patents

Methodes et compositions relatives a un facteur nucleaire regulateur specifique du muscle cardiaque Download PDF

Info

Publication number
CA2432278A1
CA2432278A1 CA002432278A CA2432278A CA2432278A1 CA 2432278 A1 CA2432278 A1 CA 2432278A1 CA 002432278 A CA002432278 A CA 002432278A CA 2432278 A CA2432278 A CA 2432278A CA 2432278 A1 CA2432278 A1 CA 2432278A1
Authority
CA
Canada
Prior art keywords
gly
ala
cys
thr
myocardin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002432278A
Other languages
English (en)
Inventor
Eric N. Olson
Da-Zhi Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2432278A1 publication Critical patent/CA2432278A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un nouveau facteur de transcription spécifique du muscle cardiaque, le myocarde. Cette molécule module le développement et la différenciation des cardiomyocytes et constitue un inhibiteur puissant de la croissance cellulaire. Par ailleurs, l'invention concerne des méthodes d'exploitation de ces observations, lesquelles consistent à respécifier les cellules non cardiaques en cellules cardiaques et à stimuler la régénération des tissus cardiaques, ainsi que des méthodes de traitement des cardiomyopathies et de l'infarctus du myocarde.
CA002432278A 2000-12-21 2001-12-21 Methodes et compositions relatives a un facteur nucleaire regulateur specifique du muscle cardiaque Abandoned CA2432278A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25771600P 2000-12-21 2000-12-21
US60/257,716 2000-12-21
PCT/US2001/050606 WO2002060946A2 (fr) 2000-12-21 2001-12-21 Methodes et compositions relatives a un facteur nucleaire regulateur specifique du muscle cardiaque

Publications (1)

Publication Number Publication Date
CA2432278A1 true CA2432278A1 (fr) 2002-08-08

Family

ID=22977449

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002432278A Abandoned CA2432278A1 (fr) 2000-12-21 2001-12-21 Methodes et compositions relatives a un facteur nucleaire regulateur specifique du muscle cardiaque

Country Status (3)

Country Link
EP (1) EP1345962A2 (fr)
CA (1) CA2432278A1 (fr)
WO (1) WO2002060946A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803765B2 (en) 1999-05-05 2010-09-28 Phylogica Limited Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
CA2568644C (fr) * 2004-06-03 2015-11-24 Phylogica Limited Modulateurs peptidiques du phenotype cellulaire et base de fragments d'acide binucleique
WO2010094757A1 (fr) * 2009-02-23 2010-08-26 F. Hoffmann-La Roche Ag Utilisation de cardiomyocytes humains primaires
BR112021003897A2 (pt) * 2018-08-30 2021-05-25 Tenaya Therapeutics, Inc. reprogramação de células cardíacas com miocarina e asci1

Also Published As

Publication number Publication date
EP1345962A2 (fr) 2003-09-24
WO2002060946A2 (fr) 2002-08-08
WO2002060946A3 (fr) 2003-06-05

Similar Documents

Publication Publication Date Title
US20050261187A1 (en) Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy
US6962798B2 (en) Methods and compositions relating to a cardiac-specific nuclear regulatory factor
US7405286B2 (en) Stars—A muscle-specific actin-binding protein
US7629308B2 (en) Methods relating to muscle selective calcineurin interacting protein (MCIP)
CA2432278A1 (fr) Methodes et compositions relatives a un facteur nucleaire regulateur specifique du muscle cardiaque
US6740751B2 (en) Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
US20040210950A1 (en) Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (CALSARCINS)
US20040029158A1 (en) HOP - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification
US7160720B2 (en) CHAMP—a novel cardiac helicase-like factor
AU2002249874A1 (en) Methods and compositions relating to a cardiac-specific nuclear regulatory factors
EP1005360A1 (fr) Proteine anti-oxydante 2, gene et procedes d'utilisation correspondants
US20040086848A1 (en) Methods and compositions using polynucleotides and polypeptides of rank-associated inhibitor (rain)
AU2002320547A1 (en) Champ-a cardiac helicase-like factor
US20020142417A1 (en) Antioxidant protein 2, gene and methods of use therefor
WO2000034524A1 (fr) Compositions et procedes se rapportant a un gene de regulation de cycle cellulaire

Legal Events

Date Code Title Description
FZDE Dead